Literature DB >> 6505282

Dose-response curve and split-dose recovery in human skin cancer.

K R Trott, B Maciejewski, G Preuss-Bayer, J Skolyszewski.   

Abstract

The data of 946 skin cancer patients treated with single doses or with 4, 8, 17, 40 or 47 fractions of X-rays were analysed using Strandquist's formalism and the linear-quadratic model. The analysis of tumour control in relation to tumour size and fractionation schedule shows a strong correlation between tumour size and tumour control rate. For small tumours, single dose irradiation was as effective as fractionated treatment. For large tumours, a straight line was easily fitted to the TCD50 and TCD90 values plotted logarithmically against time or number of fractions; the exponent for overall treatment time was 0.27 and for number of fractions it was 0.31. With the linear-quadratic model, an alpha/beta ratio of 13.8 Gy was calculated. On the assumption that the number of clonogenic cells in the tumour increases in proportion to tumour volume, Do values between 0.76 and 1.33 Gy were calculated and cellular survival curves were constructed. The estimated clonogenic fraction of tumour cells is about 10(-3); no influence of hypoxic clonogenic cells on local tumour control with single doses could be demonstrated.

Entities:  

Mesh:

Year:  1984        PMID: 6505282     DOI: 10.1016/s0167-8140(84)80048-1

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis.

Authors:  Nicholas G Zaorsky; Charles T Lee; Eddie Zhang; Scott W Keith; Thomas J Galloway
Journal:  Radiother Oncol       Date:  2017-08-23       Impact factor: 6.280

2.  Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis.

Authors:  Nicholas G Zaorsky; Charles T Lee; Eddie Zhang; Thomas J Galloway
Journal:  Radiother Oncol       Date:  2018-01-19       Impact factor: 6.280

Review 3.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Computed tomography-based flap brachytherapy for non-melanoma skin cancers of the face.

Authors:  Emile Gogineni; Haocheng Cai; Dawn Carillo; Zaker Rana; Beatrice Bloom; Louis Potters; Hani Gaballa; Maged Ghaly
Journal:  J Contemp Brachytherapy       Date:  2021-02-18

Review 5.  Clinical implementation of a new electronic brachytherapy system for skin brachytherapy.

Authors:  Olga Pons-Llanas; Rosa Ballester-Sánchez; Francisco Javier Celada-Álvarez; Cristian Candela-Juan; Teresa García-Martínez; Margarita Llavador-Ros; Rafael Botella-Estrada; Christopher A Barker; Antonio Ballesta; Alejandro Tormo-Micó; Silvia Rodríguez; Jose Perez-Calatayud
Journal:  J Contemp Brachytherapy       Date:  2014-12-31

6.  Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses.

Authors:  Rosa Ballester-Sánchez; Olga Pons-Llanas; Cristian Candela-Juan; Francisco Javier Celada-Álvarez; Christopher A Barker; Alejandro Tormo-Micó; Jose Pérez-Calatayud; Rafael Botella-Estrada
Journal:  J Contemp Brachytherapy       Date:  2016-01-28

Review 7.  Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature.

Authors:  Durim Delishaj; Agata Rembielak; Bruno Manfredi; Stefano Ursino; Francesco Pasqualetti; Concetta Laliscia; Francesca Orlandi; Riccardo Morganti; Maria Grazia Fabrini; Fabiola Paiar
Journal:  J Contemp Brachytherapy       Date:  2016-12-02

8.  A simulation model of the natural history of human breast cancer.

Authors:  S Koscielny; M Tubiana; A J Valleron
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

Review 9.  The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.

Authors:  C M van Leeuwen; A L Oei; J Crezee; A Bel; N A P Franken; L J A Stalpers; H P Kok
Journal:  Radiat Oncol       Date:  2018-05-16       Impact factor: 3.481

10.  Tumor Control Probability Modeling for Radiation Therapy of Keratinocyte Carcinoma.

Authors:  Phillip Prior; Musaddiq J Awan; J Frank Wilson; X Allen Li
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.